Category: Forbes

Report: Medical Technology Industry ‘Under-Investing’ In R&D

The medical technology industry’s R&D investments are in decline, consulting firm EY says in a new report.

We Shouldn’t Price Medications Like Designer Handbags

Nirmal Mulye, CEO of Nostrum Laboratories, said “I think it’s a moral requirement to make money when you can … to sell the product for the highest price.” Mr. Mulye’s quote doesn’t merely reflect the misguided morals of one greedy CEO. His words underp…

To Include Or Not Include Drug Prices In DTC Ads

The debate on inclusion of drug price information in DTC ads points to a much larger problem surrounding transparency. A free, competitive prescription drug market is not simply a market without price controls. It is also a market with relevant compara…

The Rising Tide Of Biotech IPO Valuations

To frame up how the Biotech IPO markets have evolved over the past six years, the author reviews data around the changes to pre-money valuations over time. The trend line is clear: up and to the right

In Blowout, Amarin’s Fish-Oil-Derived Drug Dramatically Cuts Heart Risk In Study

The results, if they hold up, are likely to result in many patients getting the medicine, and could upend decades of orthodoxy among cardiologists.

Senolytic Therapies Seem To Stop Alzheimer’s Disease “In Its Tracks”

Scientists have implicated a type of cellular stress for the first time as a player in Alzheimer’s disease. And their discovery could lead to treatments for more than 20 human brain diseases.

Senolytic Therapies Seem To Stop Alzheimer’s Disease “In Its Tracks”

Scientists have implicated a type of cellular stress for the first time as a player in Alzheimer’s disease. And their discovery could lead to treatments for more than 20 human brain diseases.

Could Senolytic Therapies Cure Aging?

“The emerging repertoire of senolytic drugs shows that they are having an impact on a huge range of diseases,” says one researcher. Scientists are looking to the new therapies to find treatments for a host of ailments that cause human beings to age.

Could Senolytic Therapies Cure Aging?

“The emerging repertoire of senolytic drugs shows that they are having an impact on a huge range of diseases,” says one researcher. Scientists are looking to the new therapies to find treatments for a host of ailments that cause human beings to age.

Building A Bridge From Direct-to-Consumer Genetic Tests To Reality

Thousands of consumers who use DTC genetic test kits learn they may carry a disease-causing genetic variant. But if they have no personal or family history of that disease, their insurance may not pay for confirmatory testing, leaving them in an abyss…